7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Jaw Diseases D007571 4 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Labyrinthitis D007762 2 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lymphocytosis D008218 2 associated lipids
Macular Degeneration D008268 5 associated lipids
Malocclusion D008310 3 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Mandibular Diseases D008336 5 associated lipids
Mandibular Injuries D008338 1 associated lipids
Measles D008457 3 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Multiple Myeloma D009101 13 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Cardiomyopathies D009202 10 associated lipids
Myocardial Infarction D009203 21 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neuroblastoma D009447 66 associated lipids
Obesity D009765 29 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Osteitis D010000 10 associated lipids
Osteitis Deformans D010001 3 associated lipids
Osteoarthritis D010003 4 associated lipids
Osteolysis D010014 8 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Osteonecrosis D010020 5 associated lipids
Osteopetrosis D010022 1 associated lipids
Osteoporosis D010024 12 associated lipids
Osteosclerosis D010026 2 associated lipids
Otosclerosis D010040 2 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Respirovirus Infections D010253 3 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Periapical Granuloma D010484 3 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Pericardial Effusion D010490 2 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Periodontal Diseases D010510 15 associated lipids
Periodontal Pocket D010514 9 associated lipids
Periodontitis D010518 22 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Periostitis D010522 1 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Polycythemia Vera D011087 13 associated lipids
Prediabetic State D011236 1 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Progeria D011371 3 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Prosthesis Failure D011475 1 associated lipids
Radicular Cyst D011842 2 associated lipids
Rheumatic Fever D012213 1 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Root Resorption D012391 2 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Osteosarcoma D012516 50 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Sclerosis D012598 5 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Stomatitis D013280 14 associated lipids
Synovitis D013585 15 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Thinness D013851 11 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tinnitus D014012 4 associated lipids
Tooth Migration D014085 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Tooth Resorption D014091 1 associated lipids
Uremia D014511 33 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Vascular Diseases D014652 16 associated lipids
Vision Disorders D014786 10 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Wounds and Injuries D014947 20 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Weight Gain D015430 101 associated lipids
Weight Loss D015431 56 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kwon A et al. Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. 2016 Medicine (Baltimore) pmid:27082605
Hsu BG et al. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. 2016 Medicine (Baltimore) pmid:27082570
Zhang L et al. Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. 2016 Braz. J. Med. Biol. Res. pmid:27074164
Song DH et al. Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. 2016 Med. Sci. Monit. pmid:27068490
Kose O et al. Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. 2016 Mar Drugs pmid:27043583
Shah AP et al. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. 2016 PLoS ONE pmid:27019421
Dela Cruz A et al. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27006198
Lis GJ et al. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. 2016 Pol. Arch. Med. Wewn. pmid:27003233
Tsuruda T et al. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. 2016 Hypertension pmid:27001297
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Moran CS et al. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966276
Cong Q et al. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. 2016 Stem Cell Reports pmid:26947973
Wang C et al. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. 2016 Med. Sci. Monit. pmid:26939934
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Bougioukli S et al. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. 2016 Bone pmid:26723577
Kobayashi Y et al. Regulation of bone metabolism by Wnt signals. 2016 J. Biochem. pmid:26711238
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Chen Z et al. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. 2016 Int. J. Mol. Med. pmid:26677102
Johnson DC et al. Genetic factors influencing the risk of multiple myeloma bone disease. 2016 Leukemia pmid:26669972
Davaine JM et al. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. 2016 Eur J Vasc Endovasc Surg pmid:26652270
Li J et al. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. 2016 Mol Med Rep pmid:26647856
Cervellati C et al. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. 2016 Oxid Med Cell Longev pmid:26635910
Alam I et al. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. 2016 Endocrinology pmid:26584014
Meijome TE et al. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. 2016 J. Cell. Biochem. pmid:26375403
Zhao N et al. Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. 2016 J. Bone Miner. Res. pmid:26274352
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Pietschmann P et al. Immunology of Osteoporosis: A Mini-Review. 2016 Gerontology pmid:26088283
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Wang S et al. Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. 2016 J Ethnopharmacol pmid:27109342
Bergamini A et al. Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. 2016 Int J Med Sci pmid:28090190
Zhou J and Zhao Y Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. 2016 Med. Sci. Monit. pmid:27828936
Ostrowska Z et al. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2016 Endokrynol Pol pmid:27828689
Kan C et al. Cancer Cell Colonisation in the Bone Microenvironment. 2016 Int J Mol Sci pmid:27782035
Huang HM et al. Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. 2016 Chin. Med. J. pmid:27779163
Kamata R et al. EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. 2016 PLoS ONE pmid:27764222
Liu HJ et al. Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. 2016 PLoS ONE pmid:27764190
Menzel J et al. Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. 2016 J. Endocrinol. Invest. pmid:27614458
O'Sullivan S et al. Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. 2016 PLoS ONE pmid:27737004
Li M et al. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. 2016 J. Biol. Chem. pmid:27697839
Shirakawa J and Kulkarni RN Novel factors modulating human β-cell proliferation. 2016 Diabetes Obes Metab pmid:27615134
Xing R et al. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. 2016 Int. J. Mol. Med. pmid:27599586
Yongdi L et al. [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27526445
Qian H et al. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. 2016 Mol Med Rep pmid:27510616
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Piemontese M et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27460899
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Ugay L et al. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. 2016 Chin. Med. J. pmid:27411457
Sun J et al. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. 2016 Int. Immunopharmacol. pmid:27576059
Li B et al. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. 2016 Int J Mol Sci pmid:27110777

Table of Content